Question Bank › Fresh evidence outrunning the reported numbers

Fresh evidence outrunning the reported numbers

Calls Tested
450
Answered YES
27
Hit Rate
6%
rare by design

Mobileye Global Inc. (MBLY) — this company's answers

NO on the Q2 2023 call 2023-07-28 B+
The model's full reasoning — Q2 2023 call → NOWe need to determine if management repeatedly grounds its case for the future in operating facts that are both fresh and early. The key is: recent developments that are already real, and management says most of their effect is still ahead. Let's scan the transcript for such statements. Amnon's opening: "On the revenue side, the quarter was in-line to better than our expectation. Customers were very cautious in the first half of 2023, which led to below normal growth but we have seen the production schedule solidify for the second half of the year, where we expect to grow 16% year-over-year on much higher volumes than the first half." That's about schedules, not necessarily fresh facts. Then: "Turning to business development for our advanced product portfolio, we continue to move more and more OEMs towards the design win phase. We can now count nine large established OEM prospects and what we consider advanced stages for products like SuperVision and Chauffeur." That's pipeline, not yet real. He talks about Volkswagen Group: "Since 2018, all new vehicles across the group have used Mobileye provided ADAS... Beginning in 2021 REM mapping functionality was added... The success of this product... led to a recent design link to Cascade REM across most of the entire group over time." That's a recent design win? "recent design link" - but it's about REM, not necessarily a huge new thing. Then "Next, we have the SuperVision design win with Porsche." That's a design win, but is it fresh? It was announced earlier. He says "While not formalized yet, we expect SuperVision to be adopted by the other premium brands" - that's expectation. He mentions "recent news on our delivery of multiple self-driving systems, which have been integrated into Volkswagen’s ID Buzz for testing" - that's testing, not production. Then he talks about ZEEKR: "We are very pleased that ZEEKR recently significantly broadened the number of users with Highway Navigate on Pilot and we expect a full rollout to all users within weeks." That's a recent expansion of users, but it's a feature rollout, not necessarily a new business development with significant revenue impact yet.

← Back to the full MBLY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management repeatedly ground its case for the company's future in OPERATING FACTS THAT ARE BOTH FRESH AND EARLY — concrete business developments that (a) began, occurred, or first became visible only within roughly the last quarter or two, (b) are already real today (actual orders, customers, shipments, openings, conversions, utilization, activity, or commitments in hand — not pipeline, interest, or plans), and (c) are explicitly described by management as only the BEGINNING of their contribution, with most of their effect still ahead of the reported results? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent evidentiary posture across the call: the strongest support for where the company is heading consists of recently-arrived, already-real developments whose weight has not yet landed in the published numbers. The developments may take any form that fits the industry — new business recently won and now beginning to flow; a product, facility, capability, or offering that recently went live and is now producing its first real activity; customers or counterparties who recently started, expanded, or converted and are now ramping; recently secured commitments now entering delivery; or a recent operational change whose measurable results have just started appearing. What matters is that management (1) points to these developments as things that actually happened or started recently — described in the past or present tense with concrete substance, not as intentions; (2) treats them, individually or together, as meaningful to the company's trajectory relative to its current size; and (3) states, directly or plainly in substance, that the results just reported capture only a small share of what these developments are expected to contribute, so the reported period understates the business as it now stands. Answer NO if management's forward case rests mainly on market conditions, industry tailwinds, pipeline, opportunity size, or general optimism rather than on identifiable recent developments already producing. NO if the cited developments are plans, negotiations, pilots without results, or contingent on approvals, financing, or decisions not yet made. NO if the recent developments are already substantially reflected in the reported results, with no meaningful contribution still ahead. NO if the fresh facts are routine in scale for this company — the ordinary cadence of wins, openings, or orders this business always reports — with no sense that they step the company beyond its current level. NO if management describes recent developments but never conveys that their contribution is still mostly ahead of the numbers. NO if the call is chiefly explaining weakness, delays, or problems with previously promised developments. NO if the posture appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
HCKT The Hackett Group, Inc. Q1 2024 2024-05-08 C
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
HUYA HUYA Inc. Q4 2023 2024-03-19 C
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
CARS Cars.com Inc. Q1 2023 2023-05-06 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
PRPO Precipio, Inc. Q3 2018 2018-11-19 D
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
WES Western Midstream Partners, LP Q3 2018 2018-10-31 D
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
MXL MaxLinear, Inc. Q2 2017 2017-08-08 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
BP BP p.l.c. Q4 2016 2017-02-07 B+
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

BRX · Q1 2023 → YESThe question is: Does management repeatedly ground its case for the company's future in OPERATING FACTS THAT ARE BOTH FRESH AND EARLY — concrete business developments that (a) began, occurred, or firs...NO The transcript repeatedly references recent leasing activity, occupancy records, and reinvestment deliveries as evidence of momentum, but these are framed as already-visible outcomes from the last quarter rather than fresh developments whose full impact is still ahead. The forward-looking elements—$60 million ABR commenced over the past year, $56 million signed but not commenced, and $38 million in forward pipeline—are explicitly described as commitments whose effects are still to come, not as already-real activity producing measurable results today. Management does not present these as concrete, early-stage facts that have begun contributing in a way that understates the reported period; instead, the case for future 2023 growth rests on guidance adjustments and expectations for continued momentum, which aligns more with industry tailwinds and pipeline size than with the required posture of fresh, already-real developments whose contribution is only beginning.
GECC · Q3 2018 → YESThe question is about whether management repeatedly grounds its case for the company's future in OPERATING FACTS THAT ARE BOTH FRESH AND EARLY. YES The transcript shows management repeatedly anchoring its forward outlook on Avanti’s three newly signed contracts (June, August, and September 2018) — concrete, already-executed deals whose revenue impact is described as “significant revenue growth… ultimately translate into significant and recurring cash flow,” with most of the effect still ahead of the Q3 numbers. This posture is reiterated in both prepared remarks and the Q&A, and Avanti is explicitly called out as the largest portfolio position. No other developments receive comparable emphasis as “fresh and early” operating facts whose contribution remains largely future-weighted. The answer is therefore YES.
BP · Q4 2016 → YESThe question is: Does management repeatedly ground its case for the company's future in OPERATING FACTS THAT ARE BOTH FRESH AND EARLY — concrete business developments that (a) began, occurred, or firs...**YES** Management repeatedly anchors its forward-looking case in concrete, recently realized operating developments that began or became visible only in the last quarter or two of 2016 and are already producing measurable activity today, with the bulk of their contribution still ahead of the reported results. Key examples include: - Six major project start-ups 2016 (In Salah Southern Fields, Point Thomson, Angola LNG, Thunder Horse water injection, Amenas compression, Thunder Horse South Expansion — the last 11 months ahead of schedule and $150 million under budget), already contributing to production and cash flow.

More from the question bank

Sequential re-ratingCustomers coming back on their ownPromise already turning into factAnswers go deeper than the scriptEscape velocity out of a small baseSold before it existsAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.